These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

56 related articles for article (PubMed ID: 22822783)

  • 1. Inhibition of cellular transfer of experimental autoimmune uveoretinitis by Rapamycin.
    Roberge FG; Kozhich A; Chan CC; Martin DF; Nussenblatt RB; De Smet MD
    Ocul Immunol Inflamm; 1993; 1(3):269-73. PubMed ID: 22822783
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Treatment of autoimmune uveoretinitis in the rat with rapamycin, an inhibitor of lymphocyte growth factor signal transduction.
    Roberge FG; Xu D; Chan CC; de Smet MD; Nussenblatt RB; Chen H
    Curr Eye Res; 1993 Feb; 12(2):197-203. PubMed ID: 8449029
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Synergistic effect of rapamycin and cyclosporin A in the treatment of experimental autoimmune uveoretinitis.
    Martin DF; DeBarge LR; Nussenblatt RB; Chan CC; Roberge FG
    J Immunol; 1995 Jan; 154(2):922-7. PubMed ID: 7814893
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Contribution of CD4+CD25+ T cells to the regression phase of experimental autoimmune uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Kijlstra A
    Invest Ophthalmol Vis Sci; 2010 Jan; 51(1):383-9. PubMed ID: 19696173
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Protective effect of the type IV phosphodiesterase inhibitor rolipram in EAU: protection is independent of IL-10-inducing activity.
    Xu H; Strassmann G; Chan CC; Rizzo LV; Silver PB; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Apr; 40(5):942-50. PubMed ID: 10102291
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Amelioration of experimental autoimmune uveoretinitis (EAU) with an inhibitor of nuclear factor-kappaB (NF-kappaB), pyrrolidine dithiocarbamate.
    Kitamei H; Iwabuchi K; Namba K; Yoshida K; Yanagawa Y; Kitaichi N; Kitamura M; Ohno S; Onoé K
    J Leukoc Biol; 2006 Jun; 79(6):1193-201. PubMed ID: 16574770
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of the ICOS/B7RP-1 T cell costimulatory pathway in murine experimental autoimmune uveoretinitis.
    Usui Y; Akiba H; Takeuchi M; Kezuka T; Takeuchi A; Hattori T; Okunuki Y; Yamazaki T; Yagita H; Usui M; Okumura K
    Eur J Immunol; 2006 Nov; 36(11):3071-81. PubMed ID: 17039566
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Staphylococcal enterotoxin B is involved in aggravation and recurrence of murine experimental autoimmune uveoretinitis via Vbeta8+CD4+ T cells.
    Kohno H; Sakai T; Tsuneoka H; Imanishi K; Saito S
    Exp Eye Res; 2009 Oct; 89(4):486-93. PubMed ID: 19523946
    [TBL] [Abstract][Full Text] [Related]  

  • 9. T-lymphocyte and experimental autoimmune uveoretinitis.
    Mochizuki M
    Jpn J Ophthalmol; 1987; 31(2):230-4. PubMed ID: 3312733
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Increased Regulatory T Cells in Spleen during Experimental Autoimmune Uveoretinitis.
    Sun M; Yang P; Du L; Zhou H; Ren X; Lin X; Kijlstra A
    Ocul Immunol Inflamm; 2010 Jan; 18(1):38-43. PubMed ID: 20128648
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adoptive transfer of experimental autoimmune uveoretinitis induced by interphotoreceptor retinoid-binding protein.
    Kawashima H; Fujiño Y; Mochizuki M
    Jpn J Ophthalmol; 1991; 35(1):51-60. PubMed ID: 1895569
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Evidence for selective accumulation of V beta 8+ T lymphocytes in experimental autoimmune uveoretinitis induced with two different retinal antigens.
    Egwuagu CE; Mahdi RM; Nussenblatt RB; Gery I; Caspi RR
    J Immunol; 1993 Aug; 151(3):1627-36. PubMed ID: 8393049
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The requirement for pertussis to induce EAU is strain-dependent: B10.RIII, but not B10.A mice, develop EAU and Th1 responses to IRBP without pertussis treatment.
    Silver PB; Chan CC; Wiggert B; Caspi RR
    Invest Ophthalmol Vis Sci; 1999 Nov; 40(12):2898-905. PubMed ID: 10549650
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Retinal antigen-specific T cells mediate experimental autoimmune uveoretinitis (EAU) in PVG rat a model for tracking antigen-specific CD4(+) T cells in the inflamed eye.
    Dick AD
    Ocul Immunol Inflamm; 1995; 3(4):261-70. PubMed ID: 22823273
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Usage of TCR Vγ2(+) T Lymphocytes in Experimental Autoimmune Uveoretinitis.
    Egwuagu CE; Smith JA; Kozhich AT; Mahdi RM
    Ocul Immunol Inflamm; 1996; 4(2):105-12. PubMed ID: 22827415
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adoptive transfer of experimental autoimmune uveoretinitis in rats. Immunopathogenic mechanisms and histologic features.
    Mochizuki M; Kuwabara T; McAllister C; Nussenblatt RB; Gery I
    Invest Ophthalmol Vis Sci; 1985 Jan; 26(1):1-9. PubMed ID: 3967952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Antigen-specific suppressor cells induced by FK506 in experimental autoimmune uveoretinitis in the rat.
    Kawashima H; Fujino Y; Mochizuki M
    Invest Ophthalmol Vis Sci; 1990 Dec; 31(12):2500-7. PubMed ID: 1702408
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The suppressive effect of triptolide on experimental autoimmune uveoretinitis by down-regulating Th1-type response.
    Wu Y; Wang Y; Zhong C; Li Y; Li X; Sun B
    Int Immunopharmacol; 2003 Oct; 3(10-11):1457-65. PubMed ID: 12946442
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Inhibition of tumor necrosis factor activity minimizes target organ damage in experimental autoimmune uveoretinitis despite quantitatively normal activated T cell traffic to the retina.
    Dick AD; McMenamin PG; Körner H; Scallon BJ; Ghrayeb J; Forrester JV; Sedgwick JD
    Eur J Immunol; 1996 May; 26(5):1018-25. PubMed ID: 8647162
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dynamics of experimental autoimmune uveoretinitis induced by adoptive transfer of S-antigen-specific T cell line.
    Chan CC; Caspi RR; Roberge FG; Nussenblatt RB
    Invest Ophthalmol Vis Sci; 1988 Mar; 29(3):411-8. PubMed ID: 3257750
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.